Morich Frank — SEC insider filings
SEC reporting owner CIK 1748615. 14 insider filings on record with FilingPulse; latest filed 2026-11-17.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2021-01-06 to 2026-11-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 3 filings — 58,000 shares, $134,002 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: purchase of 28,000 shares @ $3.75 ($105,000) in Cue Biopharma, Inc., filed 2022-05-31.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | Director | 7 | 1 leg · 28,000 sh · $105,000 | — | 6 |
| Perspective Therapeutics, Inc. (CATX) | Director | 7 | 2 legs · 30,000 sh · $29,002 | — | 6 |
Insider filings — Morich Frank
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-17 | 4 | Perspective Therapeutics, Inc. (CATX) | Purchase (P): 15,000 @ $0.94 | EDGAR |
| 2026-11-16 | 4 | Perspective Therapeutics, Inc. (CATX) | Purchase (P): 15,000 @ $1.00 | EDGAR |
| 2026-03-04 | 4 | Perspective Therapeutics, Inc. (CATX) | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Cue Biopharma, Inc. (CUE) | Grant/award (A): 24,400 (derivative) @ $0 | EDGAR |
| 2025-03-05 | 4 | Perspective Therapeutics, Inc. (CATX) | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | Cue Biopharma, Inc. (CUE) | Grant/award (A): 24,400 (derivative) @ $0 | EDGAR |
| 2024-06-24 | 4 | Perspective Therapeutics, Inc. (CATX) | Grant/award (A): 23,000 (derivative) @ $0 | EDGAR |
| 2024-01-04 | 4 | Cue Biopharma, Inc. (CUE) | Grant/award (A): 24,400 (derivative) @ $0 | EDGAR |
| 2023-12-14 | 4 | Perspective Therapeutics, Inc. (CATX) | Grant/award (A): 230,000 (derivative) @ $0 | EDGAR |
| 2023-02-23 | 4 | Perspective Therapeutics, Inc. (ISR) | Grant/award (A): 470,000 (derivative) @ $0 · Grant/award (A): 230,000 (derivative) @ $0 | EDGAR |
| 2023-01-05 | 4 | Cue Biopharma, Inc. (CUE) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2022-05-31 | 4 | Cue Biopharma, Inc. (CUE) | Purchase (P): 28,000 @ $3.75 | EDGAR |
| 2022-01-05 | 4 | Cue Biopharma, Inc. (CUE) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2021-01-06 | 4 | Cue Biopharma, Inc. (CUE) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1748615 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs